Invention Grant
US08207292B2 Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
有权
使用组氨酸脱羧酶抑制剂，LRA药物，抗H1和/或抗H2药物的组合，通过适当的组胺治疗改善COPD，胃食管反流病（GERD），食物过敏和其它胃肠病症和疾病的治疗
- Patent Title: Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
- Patent Title (中): 使用组氨酸脱羧酶抑制剂，LRA药物，抗H1和/或抗H2药物的组合，通过适当的组胺治疗改善COPD，胃食管反流病（GERD），食物过敏和其它胃肠病症和疾病的治疗
-
Application No.: US12069775Application Date: 2008-02-12
-
Publication No.: US08207292B2Publication Date: 2012-06-26
- Inventor: Michalis Nicolaou , Emile Loria , Gaetan Terrasse , Yves Trehin
- Applicant: Michalis Nicolaou , Emile Loria , Gaetan Terrasse , Yves Trehin
- Agency: Adriano & Associates
- Main IPC: C07F1/00
- IPC: C07F1/00 ; A61K38/00
Abstract:
The invention provides a method for the treatment of COPD and/or gastrointestinal disease conditions ameliorated by histamine management in a subject, comprising administering to the subject an effective amount of a histidine decarboxylase inhibitor.
Public/Granted literature
Information query
